Zhitong Finance App News, Frey Medical (300049.SZ) issued an announcement. Recently, the company received a notice from the participating company Terraclion and FDA De Novo license approval. Its core product SONOVEIN® obtained a listing license granted by the US Food and Drug Administration (FDA) through De Novo (New Medical Device Classification Application) on November 4, 2026. This product is used for vascular coagulation treatment in patients with superficial venous reflux in the large saphenous vein (GSV) segment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.